Skip to content
Open access

Programmed Death-Ligand 1 Immunohistochemical Expression in Invasive Urothelial Carcinoma of the Bladder: Association with Lymphovascular Invasion

Oct 2026 · Asian Pacific Journal of Cancer Biology · Vol 11, pp. 1093-1099 · 0 citations · 28 references

TL;DR

Clinical significance of PD-L1-positive cases in this study were identified only in tumors with lympho-vascular invasion, and because of incomplete clinical staging data and the limited sample size, the clinical significance of this observation remains uncertain and requires further validation in larger studies.

Abstract

 Introduction: Invasive urothelial carcinoma of the urinary bladder is a heterogeneous malignancy with variable biological behavior and clinical outcomes. Programmed death-ligand 1 (PD-L1) immunohistochemical expression has been widely investigated as a potential biomarker in urothelial carcinoma; however, its clinicopathological significance remains inconsistent. Materials and Methods: This analytical cross-sectional study evaluated the clinicopathological characteristics of invasive urothelial carcinoma of the bladder and analyzed their association with PD-L1 immunohistochemical expression. A total of 32 formalin-fixed, paraffin-embedded tissue samples diagnosed over a three-year period were included. The variables assessed comprised age, sex, lympho-vascular invasion, perineural invasion, tumor-infiltrating lymphocytes, and histological subtypes based on the WHO Classification of Urinary and Male Genital Tumours, 5th edition (2022). PD-L1 immunohistochemistry was performed using a monoclonal rabbit anti-human PD-L1 antibody (GeneAb™; 1:100 dilution), with tonsil tissue used as a positive control. PD L1 expression was evaluated using the Combined Positive Score (CPS), and a CPS of ≥10 was considered positive. Results: PD-L1 expression was identified in 3 of 32 cases (9.4%). A statistically significant association was found between PD-L1 expression and lympho-vascular invasion (p = 0.033). No significant association was observed between PD-L1 expression and tumor-infiltrating lymphocytes or other clinicopathological parameters. Conclusion: PD-L1-positive cases in this study were identified only in tumors with lympho-vascular invasion. However, because of incomplete clinical staging data and the limited sample size, the clinical significance of this observation remains uncertain and requires further validation in larger studies.

Read PDF

Similar papers

Open access Oct 2026

Programmed Death Ligand-1 (PD-L1) Expression in Endometrial Carcinoma: An Immunohistochemical Study and Correlation with Clinicopathological Parameters

Endometrial carcinoma (EC) is among the most prevalent gynecological malignancies worldwide, with increasing incidence linked to obesity and aging populations. Programmed death-ligand 1 (PD-L1) plays a crucial role in tumor immune evasion by interacting with PD-1, and its expression has been implicated in the aggressiv...

Rohan Bhavthankar, D. Fonseca, S. Murthy et al. · 0 citations
Open access Oct 2026

Prognostic Value of PD-L1 and Its Correlation with GATA3, CK5/6, and CK14 Expression in Muscle-Invasive Bladder Cancer.

BACKGROUND Muscle-invasive bladder cancer (MIBC) is an aggressive urothelial carcinoma with poor outcomes. This study investigated programmed death ligand 1 (PD-L1) expression and its association with key immunohistochemical markers (GATA3, CK5/6, CK14) and overall survival (OS). METHODS We analyzed formalin-fixed, p...

S. Sangkhathat, Kanet Kanjanapradit, Tanan Bejrananda et al. · 0 citations
Open access Oct 2026

Prevalence and Prognostic Significance of Programmed Death-Ligand 1 Expression in Breast Carcinoma Patients from Central India

Breast carcinoma remains the most common cancer among women worldwide and a leading cause of cancer-related deaths. In India, both incidence and mortality are steadily rising, with younger women being disproportionately affected. Programmed death-ligand 1 (PD-L1) expression has emerged as a potential biomarker that...

R. Krishnan, B. U. Patil, Anand Krishnan et al. · 0 citations
Aug 2026

Clinicopathological significance of PLAC1 expression in patients with bladder urothelial carcinoma

Ectopic expression of Placenta-specific 1 (PLAC1), a Cancer/Testis Antigen (CTA), was reported in various tumors, but its clinical relevance and prognostic value in bladder urothelial carcinoma (UC) remain unclear. This study evaluated PLAC1 expression in the membrane, cytoplasm, and nucleus of tumor cells and its clin...

Shima Dorafshan, Zahra Madjd, Leili Saeednejad Zanjani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.